Ascend Wellness Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Samuel Brill
- Full Time Employees
- 2,300
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1411 Broadway Morristown NY United States of America 10018
- IPO Date
- May 26, 2021
- CIK
- 0001756390
- Website
- awholdings.com
- Similar Companies
- Business
- Ascend Wellness Holdings, Inc. is a vertically integrated cannabis company engaged in the cultivation, production, distribution, and retailing of cannabis products across the United States. The company’s core products include cannabis flower, pre-rolls, concentrates, vaporizer cartridges, capsules, tinctures, edibles, and topicals. Ascend operates seven state-of-the-art cultivation facilities and a retail network consisting of 46 dispensaries nationwide, serving key markets such as Illinois, Massachusetts, New Jersey, and Ohio. Founded in 2018 and headquartered in New York City, Ascend Wellness Holdings targets adult-use and medical cannabis consumers, focusing on premium, award-winning strains and curated product selections. In terms of recent developments, Ascend Wellness has expanded its retail footprint with seven new stores added in 2025 alone, and aims to grow its store count by approximately 50% with an additional 20 locations projected in the midterm. The company launched a fully refreshed eCommerce platform featuring the Ascenders Club, a four-tiered loyalty program designed to enhance customer engagement through personalized rewards and benefits. In 2025, Ascend introduced the new brand "Effin" which has performed strongly in edibles and launched the Ethn brand focused on targeted effects, now a top-selling edible brand in its stores. The company also completed a $50 million private placement of senior secured notes and successfully refinanced a $60 million term loan to strengthen its balance sheet, alongside executing an 11 million share buyback representing 5% of its outstanding shares. Operational strategies have focused on margin optimization with a 24.9% adjusted EBITDA margin achieved in Q3 2025 and a 300 basis point sequential increase in adjusted gross margin, supporting sustainable growth and profitability goals. Ascend maintains a robust cash position to fund continued strategic expansion and innovation across its vertically integrated cannabis operations.
Ascend Wellness Q1 Earnings Call Highlights
Ascend Wellness Holdings, Inc. (AAWH) Q1 2026 Earnings Call Transcript
Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates
AWH Reports First Quarter 2026 Financial Results
Analysts Estimate Ascend Wellness Holdings, Inc. (AAWH) to Report a Decline in Earnings: What to Look Out for
Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript
AWH to Hold First Quarter 2026 Earnings Conference Call on Wednesday, May 13, 2026
Ascend Wellness Holdings Announces the Opening of East Coasting Dispensary in Eatontown, New Jersey
3 Top Marijuana Stocks For Better Trading And Investing
Ascend and NuProject Launch ROOTS Program to Prepare Cannabis Businesses for Corporate Supply Chains
New Strong Sell Stocks for April 6th
Ascend Wellness Holdings, Inc. (AAWH) Q4 2025 Earnings Call Transcript
Ascend Wellness Holdings, Inc. (AAWH) Reports Q4 Loss, Beats Revenue Estimates
AWH Announces Fourth Quarter and Full Year 2025 Results
Ascend Wellness Holdings Unveils a Full Relaunch of Its Ozone Brand
3 Top Marijuana Stocks to Watch Before March 2026
AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date
New Strong Sell Stocks for February 2nd
New Strong Sell Stocks for January 28th
Ascend Wellness (OTC:AAWH) Stock Price Up 4.6% – Here’s What Happened